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Abstract
Background Low anterior resection syndrome (LARS) is a defecation disorder that frequently occurs after a low
anterior resection (LAR) with a total mesorectal excision (TME). The transanal (ta) TME for low rectal pathologies
could potentially overcome some of the difficulties encountered with the abdominal approach in a narrow pelvis.
However, the impact of the transanal approach on functional outcomes remains unknown. Here, we investigated the
effect of the taTME approach on functional outcomes by comparing LARS scores between the LAR and taTME
approaches in patients with colorectal cancer.
Methods We conducted a retrospective cohort study including 80 patients (n = 40 LAR-TME, n = 40 taTME) with
rectal adenocarcinoma. We reviewed medical charts to obtain LARS scores 6 months after the rectal resection or a
reversal of the protective ileostomy.
Results At the 6-month follow-up, 80% of patients exhibited LARS symptoms (44% minor LARS and 36% major
LARS). LARS scores were not significantly associated with the T-stage, N-stage, or neo-adjuvant radiotherapy. The
mean distance of the anastomosis from the anal verge was 4.0 ± 2.0 cm. The taTME group had significantly lower
anastomoses compared with the LAR-TME group (median 4.0 cm [IQR1.8] vs. median 5.0 cm [IQR 2.0],
p\ 0.001). Univariable analysis revealed significantly higher LARS scores in the taTME group compared with the
LAR-TME group (median LARS scores: 29 vs. 25, p = 0.040). However, multivariable regression analysis, adjusting
for neo-adjuvant treatment, anastomosis distance from the anal verge, anastomotic leak rate, and body mass index,
revealed no significant effect of taTME on the LARS score (adjusted regression coefficient: - 2.147, 95%CI:
- 2.130 to 6.169, p = 0.359). We also found a significant correlation between LARS scores and the distance of the
anastomosis from the anal verge (regression coefficient: - 1.145, 95%CI: - 2.149 to - 1.141, p = 0.026).
Conclusion Fifty percentage of patients in this cohort exhibited some LARS symptoms after a mid- or low-rectal
cancer resection. As previously described, LARS scores were negatively correlated with the distance of the anas-
tomosis from the anal verge. TaTME was after adjustment for the height of the anastomosis not associated with
higher LARS at 6 months when compared with LAR-TME.
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Introduction
In the past few decades, surgical treatment has significantly
changed for patients with rectal cancer. Generally, the
outcome for patients with rectal cancer [1] has significantly
improved, due to the adoption of the total mesorectal
excision (TME) [2] as a standard of care and the progress
made in neo-adjuvant and adjuvant therapy. Currently, the
open technique has increasingly been replaced with mini-
mally invasive techniques. The benefits of minimally
invasive surgery include a shorter hospital stay, fewer
surgical site infections, and less postoperative pain. Nev-
ertheless, studies have failed to show superiority for the
minimally invasive approach, based on histopathological
outcomes [3, 4]. Additionally, minimally invasive tech-
niques cannot always overcome the technical difficulties of
an oncological resection in a narrow male pelvis or the
resection of a bulky malignancy in the mid-to-lower rec-
tum. In these cases, the dissection of the mesorectal fascia
sometimes cannot be completed down to the muscular
pelvic floor. Recently, transanal (ta) TME evolved as a
promising new technical variant to circumvent the prob-
lems associated with anterior rectal cancer resections in the
lower pelvis [5]. This ‘bottom up’ approach potentially
provides a better view for the dissection of the mesorectal
fascia in the lower pelvis and allows a safe oncologically
correct resection [6]. However, we lack studies that
investigated the impact of the bottom-up approach on
functional outcomes. As a complication after a rectal
cancer resection, up to 80% of patients experience a
complex of defecation problems, known as low anterior
resection syndrome (LARS), and up to 50% experience
severe defecation problems (major LARS) with impaired
quality of life [7–9]. Therefore, the present study investi-
gated the effect of the taTME approach on functional
outcomes by comparing LARS scores between the LAR-
TME and taTME treatments for patients with colorectal
cancer. We hypothesized that the surgical technique, i.e.,
taTME vs. LAR-TME, does not affect LARS scores.
Materials and methods
Study design and patient inclusion
A retrospective cohort study was performed including 80
patients undergoing rectal cancer resection at the Depart-
ment of Visceral Surgery and Medicine in the University
Hospital of Bern, Switzerland from 2012 to 2017. This
study meets the criteria of the STROBE guidelines (www.
strobe-statement.org). LARS scores were routinely recor-
ded in our outpatient clinic for all patients that underwent a
resection of the rectum. For this study, we retrospectively
retrieved data from electronic patient charts. We analyzed
LARS scores of patients treated for rectal adenocarcinoma
with the LAR-TME (laparoscopic or open) or the taTME
approach in our tertiary center. We adopted taTME in our
institution after formal training in 2015. Therefore, the
LAR-TME group included a series of consecutively treated
patients with the traditional LAR approach between 2012
and 2015, and the taTME group correspondingly included
the first patients treated with the transanal approach
between 2015 and 2017.
We analyzed the LARS scores recorded six months after
closure of the protective loop ileostomy or six months after
resection of the rectum, in patients without a diverting
ileostomy. We used the LARS score validated by
Emmertsen et al. [10] and the following proposed cate-
gories: 0–20 points indicated ‘No LARS,’ 21–29 points
indicated ‘Minor LARS,’ and 30–42 points indicated
‘Major LARS.’ All procedures were performed by two
fully trained colorectal surgeons.
All patients were preoperatively evaluated at the mul-
tidisciplinary team (MDT) meeting for colorectal cancer.
Patients received surgery alone or neo-adjuvant treatment,
according to the S3 guidelines (https://www.awmf.org/lei
tlinien/detail/ll/021-007OL.html) and the decision made at
the MDT meeting.
Perioperative management
All patients underwent a mechanical bowel preparation the
day before surgery and received prophylactic intravenous
antibiotics before the skin incision.
LAR-TME: A medial-to-lateral approach was used in
laparoscopic treatments and a lateral-to-medial approach
was used for open surgery, as described elsewhere [11]. A
high-tie of the inferior mesenteric artery was performed.
The superior mesenteric vein was dissected at the inferior
border of the pancreas. The splenic flexure was mobilized
in all patients.
TaTME: A Gelpoint (Applied Medical, California,
USA) and Airseal system (Conmed, New York, USA) was
used as previously described [12]. All taTMEs were per-
formed in a two-team procedure. The specimen was
retrieved through an abdominal incision (Pfannenstiel or
periumbilical mini-laparotomy). The anastomosis of the
descending colon to the rectum was performed end–end or
side–end with a circular stapler. For very low malignan-
cies, we fashioned a hand-sewn end-end anastomosis (colo-
anal pull through). 88% of patients received a protective
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diverting loop ileostomy. The postoperative period was
guided by the enhanced recovery after surgery guidelines
[13].
We obtained approval from the local Ethics Board
(Ethics committee of the Canton of Berne Switzerland,
registration number: 2018–01,911) before study initiation.
Statistical analysis
Missing data were found in two variables (TNM lymph
node stage and time to stoma reversal) and reported in the
baseline characteristics (Table 1). The normality of distri-
bution of continuous variables was assessed using his-
tograms, skewness, and the Shapiro–Wilk test. Categorical
variables were compared with Fisher’s exact test or Pear-
son’s chi-square test. Continuous variables were analyzed
with the Mann–Whitney U test. Results were reported as
the number and percentage or the median and interquartile
range (IQR), as appropriate. P values\ 0.05 were con-
sidered statistically significant.
The effect of the taTME technique on the LARS score at
6 months postoperatively was analyzed in multivariable
linear regression analysis adjusted for other clinically
important variables. Clinically important variables were
correlated with the LARS score at 6 months in univariable
analysis. Variables with p values\ 0.1 were entered in the
multivariable regression model. Interactions between the
taTME technique and other independent variables included
in the regression model were assessed in separate regres-
sion analyses. The degree of multicollinearity between
predictor variables was assessed using the variance infla-
tion factor (VIF). A VIF\ 5 was assumed to exclude
significant collinearity. Results of the multivariable
regression analysis were expressed as regression coefficient
(RC) and 95% confidence interval (95%CI). Statistical
analyses were performed with SPSS Statistics (IBM Cor-
poration, Armonk, New York, USA).
Results
Patients and tumor characteristics
Among the 80 patients studied (n = 40 LAR-TME, n = 40
taTME), the majority were male (n = 53, 66%), median
age was 62 years (IQR 25), and median BMI 25 kg/m2
(IQR 5.4). At the time of diagnosis, 39 patients (49%)
presented with malnutrition (nutritional risk scores C 3,
[14]) and received nutritional support before the resec-
tion. Overall, 48 (58%) participants had significant
comorbidities, defined as an American Society of Anes-
thesiologists score C 3. Forty-four (55%) patients received
neo-adjuvant treatment. Patient characteristics were not
significantly different between the taTME and LAR-TME
groups (Table 1).
We found a T-stage C 3 in 35 (44%) patients and a
positive N-stage in 27 (34%) patients, with no significant
difference between the groups. Overall, the median dis-
tance from the anal verge (AV) to the distal end of the
tumor was 8.0 cm (IQR 5 cm). The median tumor height
from the AV was significantly lower in the taTME group
compared with the LAR-TME group (7.0 cm [IQR 5.0] vs.
9.0 cm [IQR 4.0], p = 0.023; Table 1).
Surgery-related data and histopathology
Overall, the median operative time was 300 min (IQR
100). The operative time was significantly shorter in the
taTME compared with the LAR-TME group (320 min
[IQR 98] vs. 275 min [IQR 98], p = 0.010). In addition,
intraoperative blood loss was significantly lower in patients
undergoing taTME compared with LAR-TME (200 ml
[IQR 238] vs. 400 ml [IQR 288], p = 0.014). The median
anastomotic height (distance from the AV to the anasto-
mosis) was significantly lower in theTME compared with
the LAR-TME group (4 cm [IQR1.8] vs. 5 cm [IQR 2.0],
p\ 0.001). A stapled anastomosis was performed in 68
(85%) patients. The remaining patients received a hand-
sewn anastomosis. The hand-sewn anastomosis was per-
formed significantly more frequently in the taTME vs. the
LAR-TME group (n = 10 [25%] vs. n = 2 [5%],
p = 0.025). Overall, 71 (88.8%) patients received a pro-
tective loop ileostomy. The surgical specimen (MER-
CURY 1) was of good quality in 35 (87.5%) patients in the
LAR-TME group and in 37 (92.5%) patients in the taTME
group (p = 0.549). A positive circumferential resection
margin (CRM) was found in three (3.8%) patients in the
LAR-TME group and no patients in the taTME group
(p = 0.241).
Overall, protective loop ileostomies were closed at a
median of 118 days (IQR 147) after rectal surgery. Median
time to stoma closure was comparable between the LAR-
TME and taTME group (123.5 days [IQR 145] vs.
118.0 days [IQR 150] p = 0.803). Moreover, the time to
stoma closure after resection had no impact on the LARS
scores at 6 months (Fig. 1). No significant association
between anastomotic leakage and the time of stoma closure
was found (median 131 [IQR 137] vs. 114 [IQR 139] days,
p = 0.308), as well as in the taTME (median 131 [IQR 145]
vs. 104 [IQR 140], p = 0.294) and LAR-TME (median 155
[IQR 182] vs. 123 [IQR 141] days, p = 0.716) group. We
detected an anastomotic leak in nine (11.3%) patients. The
leakage rates were not significantly different between
groups (LAR-TME n = 4 [10%] vs. taTME n = 5 [12.5%];
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p = 1.000). However, anastomotic leakage was associated
with high LARS scores. The median LARS score was 34
(IQR 9) for patients with leakage and 26 (IQR 10) for
patients without leakage (p = 0.259).
LARS score
The LARS scores at six months after closure of the
ileostomy or after resection of the rectum (in cases where
no stoma was created) were evaluated (Fig. 1). The median
overall LARS score was 27 (IQR 12). A total of 64 (80%)
patients presented with LARS symptoms, including fecal
incontinence or urgency, frequent or fragmented bowel
movements, emptying difficulties, or increased intestinal
gas. Of the 64 patients with LARS symptoms, 35 (44%)
had minor LARS (44%) and 29 (36%) had major LARS.
LARS symptoms were present in 30 (75%) patients in the
LAR-TME group and 34 (85%) in the taTME group.
The proportions of no LARS, minor LARS, and major
LARS were not significantly different between the LAR-
TME and taTME groups (p = 0.249). Univariable analysis
Table 1 Baseline characteristics
Patient characteristics All LAR-TME taTME p value
(n = 80) (n = 40) (n = 40)
Age (y)* 62.0 (25.0) 60.5 (23.0) 62.0 (29.0) 0.862#
BMI (kg/m2)* 25.0 (5.3) 24.3 (6.4) 25.3 (5.0) 0.583#
Male sex 53 (66.3) 26 (65.0) 27 (67.5) 1.000
ASA Classification
1 8 (10.0) 2 (5.0) 6 (15.0) 0.215
2 24 (30.0) 11 (27.5) 13 (32.5)
3 42 (52.5) 25 (62.5) 17 (42.5)
4 6 (7.5) 2 (5.0) 4 (10.0)
Neo-adjuvant treatment 44 (55) 20 (50.0) 24 (60.0) 0.500
NRS C 3 39 (48.8) 20 (50.0) 19 (47.5) 1.000
Tumor characteristics
Tumor distance from AV (cm)* 8.0 (5.0) 9.0 (4.0) 7.0 (5.0) 0.023#
TNM T-stage
0 5 (6.3) 3 (7.5) 2 (5.0) 0.302
1 19 (23.8) 8 (20.0) 11 (27.5)
2 21 (26.3) 11 (27.5) 10 (25.0)
3 28 (35.0) 12 (30.0) 16 (40.0)
4 7 (7.8) 6 (15.0) 1 (2.5)
TNM N-stage positive 27/79 (33.8) 11/39 (28.2) 16/40 (40.0) 0.344
Surgery-related data 
Anastomosis distance from AV (cm)* 4.0 (2.0) 5.0 (2.0) 4.0 (1.8) \ 0.001#
Operative time (min)* 300 (100) 320 (98) 275 (98) 0.010#
Blood loss (ml)* 300 (300) 400 (288) 200 (238) 0.014#
Stapled anastomosis 68 (85) 38 (95) 30 (75) 0.025
Loop ileostomy 71 (89) 36 (90.0) 35 (87.5) 1.000
Mercury
1 72 (90.0) 35 (87.5) 37 (92.5) 0.549
2 7 (8.8) 4 (10.0) 3 (7.5)
3 1 (1.3) 1 (2.5) 0 (0.0)
CRM positive 3 (3.8%) 3 (7.5) 0 (0.0) 0.241
Anastomotic leak 9 (11.3) 4 (10.0) 5 (12.5) 1.000
Time to stoma closure, n = 75 (days)* 118 (147) 123 (145) 118 (150) 0.803#
Values are numbers (percentages) of patients, unless indicated otherwise. *Values are medians (interquartile range). Fisher’s exact test, unless
indicated otherwise. Pearsons’s chi-square test. #Mann–Whitney U test
BMI Body Mass Index, ASA American Society of Anesthesiologists, NRS nutritional risk score, AV anal verge, CRM circumferential resection
margin
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showed that median LARS scores were significantly higher
in the taTME group compared with the LAR-TME group
(29 [IQR 13] vs. 25 [IQR 11], p = 0.040). However, in
multivariable regression analysis, after adjusting for neo-
adjuvant treatment, anastomosis distance from the AV, the
anastomotic leak rate, and BMI, the taTME approach was
not significantly associated with LARS scores (adjusted
regression coefficient (RC) 2.011, 95%CI - 2.147 to
6.169, p = 0.338). The variables tested in the multivariable
regression model showed no significant interactions or
colinearity (VIF\ 5 for all variables). Large distances
between the anastomosis and the AV were associated with
significantly lower LARS scores (regression coefficient
- 1.145, 95%CI: - 2.149 to - 1.141, p = 0.026; Fig. 2).
The time to stoma closure (days) was associated with
higher LARS scores, but this effect was not statistically
significant (regression coefficient 0.013, 95%CI: - 0.003
to 0.029, p = 0.114). No significant association between
LARS and male sex compared with female sex was found
(Table 2). LARS scores were not significantly higher in
patients after an anastomotic leakage compared with
patients without leakage (median 36 [IQR 18] vs. 27 [IQR
10], p = 0.259).
To determine whether the learning curve might have
affected the implementation of the taTME, we compared
the tumor height and the distance of the anastomosis from
the AV in our first 20 cases to those in the consecutive 20
cases of this cohort. We found no significant differences
between the first and second 20 patients that underwent
taTME in the median tumor height (7.0 cm [IQR 7.0] vs.
7.0 cm [IQR 4.0]; p = 0.838) or the median distance of the
anastomosis from the AV (4.0 cm [IQR 3.0] vs. 4.0 cm
[IQR 1.0]; p = 0.380). Finally, we have not observed any
local recurrences at the time of the analysis of this cohort.
Discussion
Some concern has arisen over the functional outcomes after
taTME, due to the placement of a large port in the anal
canal for a relatively long time period. In this study, we
evaluated the LARS score as a surrogate marker for ano-
rectal function after TME [15] [16]. We compared out-
comes between our first consecutive 40 taTME operations
and 40 LAR-TME operations performed prior to the
introduction of taTME in our institution. We found that the
taTME approach did not negatively impact the LARS
scores.
The groups had similar overall patient characteristics
and rectal tumor characteristics, except for the tumor dis-
tance from the AV. We observed significantly lower
tumors in the taTME group than in the LAR-TME group.
This finding can be explained by the fact that the taTME
technique was preferred for treating lower tumors, and the
LAR-TME was preferred over the taTME for treating high
rectal tumors, particularly in female patients, in our insti-
tution. Accordingly, we found significantly lower anasto-
moses in the taTME compared with the LAR-TME group.
Consistent with this result, the hand-sewn pull-through
type of anastomosis was used significantly more frequently
in the taTME group than in the LAR-TME group.
We found that the operative time was significantly
shorter in patients undergoing taTME compared with LAR-
TME. This result can be explained by the fact that the
taTME was always performed with a two-team approach.
Additionally, we observed significantly less blood loss with
the taTME vs. the LAR-TME approach. We hypothesize
that this finding reflects the improved view of the dissec-
tion plane, and, therefore, the greater safety in lower pelvis
dissections performed with the taTME compared with the
LAR-TME approach. A pathological examination of the
surgical specimens showed no differences between the
groups in terms of the Mercury grade or the CRM posi-
tivity. However, we observed a tendency toward more
Grade 1 Mercury specimens and less CRM positive spec-
imens in the taTME group compared with the LAR-TME
group, as reported previously [17].
As described in several previous studies, we confirmed
that a high percentage of patients showed LARS symptoms
after the oncological resection of the rectum [9]. In our
cohort, 80% of patients presented with LARS symptoms,
and of those, 36% had severe major LARS. However, a
detailed analysis showed that the incidences of minor and
major LARS were not different between the taTME and
LAR-TME groups (Fig. 1). Univariate analysis showed a
Fig. 1 LARS scores after LAR TME vs. taTME 6 month after
ileostomy closure. Number of patients with no LARS minor LARS
and major LARS in the LAR-TME group (blue, n = 40) compared
with the taTME group (red, N = 40). ‘‘Fisher’s exact test’’ LARS:
Low anterior resection syndrome. LAR TME: Low anterior
resection and total mesorectal excision. taTME Transanal total
mesorectal excision.
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higher major LARS rate after the taTME compared with
the LAR-TME. This can be explained by the significantly
lower level of anastomosis with the taTME (Fig. 2). Fur-
thermore, we demonstrated a significant correlation
between the anastomosis distance from the AV and the
severity of LARS, which is generally accepted in the field.
The other parameters studied in our cohort did not have a
negative impact on LARS symptoms. In particular, the
BMI, neo-adjuvant treatment, time to stoma closure, and
anastomotic leakage had no statistical impact on LARS
symptoms in either group.
In our opinion, the taTME has technical advantages over
the LAR-TME approach for oncological resections of low
rectal tumors that require a full TME. These advantages are
most striking when the TME is performed in a difficult
male pelvis or to remove bulky, low tumors (\ 10 cm). In
the case of very low rectal malignancies, the transanal
approach might enable the possibility for a correct onco-
logical resection with an anastomosis instead of an ampu-
tation. However, the taTME is a demanding surgical
procedure with relevant pitfalls, and it requires standard-
ized training [18]. Furthermore, as demonstrated in the
current study, lower anastomoses are associated with a
higher complication rate, including LARS. Consequently,
very low colorectal anastomoses should be avoided
whenever possible and oncologically safe, regardless of the
technique used for rectal resections.
We believe that the taTME procedure should be in the
armamentarium of colorectal surgeons in specialized units
treating low rectal pathologies. The technique should be
restricted to selected patients (mainly male patients with
low pathologies, especially bulky malignancies). Com-
pared with open and laparoscopic surgery, the robotic
approach offers technical benefits in the low pelvis as well
and is of course a contender in this type of surgery.
This study had some relevant limitations. The retro-
spective design had inherent limitations. The temporal
separation of the cohorts might have resulted in a selection
bias (significantly lower tumors in the taTME cohort).
Furthermore, we obtained no quality of life questionnaires
and focused solely on the LARS score to assess ano-rectal
function after the rectal resection. However, several pre-
vious studies revealed a solid correlation between the
LARS score and bowel-related quality of life [7]. Despite
these limitations, this study adds valuable data regarding
the functional outcome in patients undergoing taTME.
In conclusion, taTME was after adjustment for the
height of the anastomosis not associated with higher LARS
Fig. 2 LARS scores correlate
with the distance of the
anastomosis from the anal
verge. Six-month LARS scores
decrease with increasing
distance between the
anastomosis and the anal verge
at the 6 month time point. CI:
Confidence interval. LARS:
Low anterior resection
syndrome
Table 2 Association between male/female sex and LARS
No LARS Minor LARS Major LARS p value
(n = 16) (n = 35) (n = 29)
Male sex
Female sex
10 (18.9) 24 (45.3) 19 (35.8) 0.953
6 (22.2) 11 (40.7) 10 (37.0)
No LARS or minor LARS Major LARS
Male sex
Female sex
34 (64.2)
17 (63.0)
Median LARS
19 (35.8) 1.000
10 (37.0)
IQR
Male sex 26
29
13 0.939#?
Female sex 11
Values are numbers (percentages) of patients, unless indicated
otherwise
Fisher’s exact test, unless indicated otherwise. #?Mann–Whitney
U test
LARS Low anterior resection syndrome, IQR interquartile range
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at 6 months when compared with LAR-TME. Further
studies are warranted, especially to analyze the long-term
oncological outcome.
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